首页> 外国专利> Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy

Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy

机译:植物大麻素大麻二酚(cbd)与标准抗癫痫药(saed)联合用于治疗癫痫的用途

摘要

Provided is a combination of cannabidiol (CBD) at a dose greater than 300mg/day and a standard anti-epileptic drug (SAED) which acts via sodium or calcium channels. Disclosed SAEDs include ethosuximide, valproate, and phenobarbital.
机译:提供了剂量大于300毫克/天的大麻二酚(CBD)和通过钠或钙通道起作用的标准抗癫痫药(SAED)的组合。公开的SAED包括ethosuximide,丙戊酸盐和苯巴比妥。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号